HealthTech
PrognomiQ
PrognomiQ raises $34M Series D at $180M valuation
$34M
Total Raised
Series D
Latest Round
2019
Founded
80+
Employees
San Mateo, CA
1 min read
Quick Facts
Valuation
$180M
Latest Round Size
$34M
Latest Round Date
November 2024
PrognomiQ: Series D Funding Round
PrognomiQ has successfully raised $34M in Series D funding, reaching a valuation of $180M.
Company Overview
Healthcare company developing multi-cancer early detection tests
Funding Details
The Series D round was led by Seer, with participation from Casdin Capital.
Company Information
- Headquarters: San Mateo, CA
- Founded: 2019
- Employees: 80+
- Category: HealthTech
Investment
PrognomiQ plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Seer: Verified investor in Series D
- Casdin Capital: Verified investor in Series D
Key Investors
Seer
Lead Investor
Verified investor in Series D
Casdin Capital
Investor
Verified investor in Series D
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
HealthTech
Zingage
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
Editorial Team
Oct 9, 2025
1 min read•$12.5M
HealthTech
AccelerateStack Platform
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Michael Rodriguez
Oct 8, 2025
3 min read•$75M
HealthTech
Duos
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...
Editorial Team
Oct 8, 2025
1 min read•$130M